We are live on ! Find out more
KA

Keene & Associates Portfolio holdings

AUM $125M
1-Year Est. Return 13.49%
This Fund
S&P 500
This Quarter Est. Return
-8.29%
1 Year Est. Return
+13.49%
3 Year Est. Return
+20.33%
5 Year Est. Return
10 Year Est. Return
AUM
$109M
AUM Growth
+$2M
Cap. Flow
+$12.9M
Cap. Flow %
11.86%
Top 10 Hldgs %
36.73%
Holding
83
New
3
Increased
44
Reduced
22
Closed
5

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$2.69M
2
MCK icon
McKesson
MCK
+$891K
3
ADBE icon
Adobe
ADBE
+$434K
4
SYNA icon
Synaptics
SYNA
+$226K
5
PFE icon
Pfizer
PFE
+$138K

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.83%
2 Healthcare 20.32%
3 Technology 12.94%
4 Industrials 7.77%
5 Energy 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MINT icon
1
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
$10.9M 9.98%
+109,895
New +$10.9M
CVX icon
2
Chevron
CVX
$388B
$3.7M 3.4%
25,772
+112
+0.4% +$17.1K
MRK icon
3
Merck
MRK
$324B
$3.58M 3.29%
41,585
-535
-1% -$47.8K
SLB icon
4
SLB Ltd
SLB
$77.8B
$3.32M 3.05%
92,410
+85,225
+1,186% +$3.09M
BMY icon
5
Bristol-Myers Squibb
BMY
$127B
$3.31M 3.04%
46,580
+7
+0% +$508
WMT icon
6
Walmart Inc
WMT
$871B
$3.2M 2.94%
74,055
+1,497
+2% +$65.6K
PEP icon
7
PepsiCo
PEP
$186B
$3.14M 2.89%
19,238
-236
-1% -$40.7K
GD icon
8
General Dynamics
GD
$105B
$3.03M 2.79%
14,298
+68
+0.5% +$15.4K
JNJ icon
9
Johnson & Johnson
JNJ
$635B
$2.92M 2.68%
17,867
-171
-0.9% -$28.9K
CSCO icon
10
Cisco
CSCO
$450B
$2.9M 2.67%
72,516
+8,551
+13% +$379K
B
11
Barrick Mining
B
$62.2B
$2.88M 2.65%
185,981
+31,729
+21% +$501K
INGR icon
12
Ingredion
INGR
$6.38B
$2.88M 2.65%
35,752
+367
+1% +$32.2K
DUK icon
13
Duke Energy
DUK
$102B
$2.83M 2.6%
30,367
+414
+1% +$44.5K
UL icon
14
Unilever
UL
$131B
$2.81M 2.58%
57,043
+1,871
+3% +$97.8K
TAP icon
15
Molson Coors Class B
TAP
$7.68B
$2.8M 2.57%
58,381
-1,926
-3% -$104K
KR icon
16
Kroger
KR
$34.8B
$2.73M 2.5%
62,278
+2,070
+3% +$98.3K
BWA icon
17
BorgWarner
BWA
$13.2B
$2.72M 2.5%
98,354
+5,293
+6% +$171K
PFE icon
18
Pfizer
PFE
$140B
$2.72M 2.5%
62,080
-2,850
-4% -$138K
MSFT icon
19
Microsoft
MSFT
$2.84T
$2.71M 2.49%
11,637
+8
+0.1% +$2.11K
KMB icon
20
Kimberly-Clark
KMB
$36.4B
$2.7M 2.48%
23,983
+517
+2% +$67.2K
NEM icon
21
Newmont
NEM
$98.2B
$2.66M 2.45%
63,350
+3,839
+6% +$179K
MDT icon
22
Medtronic
MDT
$107B
$2.61M 2.4%
32,342
+1,358
+4% +$122K
TSN icon
23
Tyson Foods
TSN
$20.2B
$2.55M 2.35%
38,721
+1,009
+3% +$79.8K
DIS icon
24
Walt Disney
DIS
$165B
$2.52M 2.32%
26,716
+1,939
+8% +$208K
ORCL icon
25
Oracle
ORCL
$331B
$2.46M 2.26%
40,291
+1,259
+3% +$92.2K

Similar funds

Keene & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Keene & Associates held 83 positions worth $109M, up 1.9% from $107M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Keene & Associates deployed $12.9M of net new capital in Q3 2022, opening 3 new positions and adding to 44 existing holdings. Its largest new stake was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 109,895 shares worth $10.9M.

By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was McKesson, an estimated $891K trimmed.

  • Keene & Associates's largest Q3 2022 buy was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 109,895 shares worth $10.9M.
  • Keene & Associates added most to SLB Ltd in Q3 2022, an estimated $3.09M increase.
  • Keene & Associates's biggest Q3 2022 reduction was McKesson, cutting an estimated $891K.
  • Keene & Associates fully exited 3M in Q3 2022, selling an estimated $2.69M.
  • Keene & Associates's ten largest holdings make up 37% of its $109M portfolio in Q3 2022.
  • Keene & Associates opened 3 new positions and closed 5 in Q3 2022.
  • Keene & Associates's portfolio value rose 1.9% quarter-over-quarter to $109M.

Based on Keene & Associates's 13F filing for Q3 2022, filed 1 Nov 2022.